MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.

Jeffrey J Tosoian,Michael S Sessine,Bruce J Trock,Ashley E Ross,Cassie Xie,Yingye Zheng,Nathan L Samora,Javed Siddiqui,Yashar Niknafs,Zoey Chopra,Scott Tomlins,Lakshmi P Kunju,Ganesh S Palapattu,Todd M Morgan,John T Wei,Simpa S Salami,Arul M Chinnaiyan

Prostate cancer and prostatic diseases（2022）

引用 1|浏览22

暂无评分

摘要

In patients who previously underwent a negative prostate biopsy, the MyProstateScore values of 15 and 40 yielded clinically-actionable rule-in and rule-out risk groups. Using this straightforward testing approach, MyProstateScore can meaningfully inform patients and physicians weighing the need for repeat biopsy.

查看译文

关键词

Cancer screening,Predictive markers,Biomedicine,general,Cancer Research,Reproductive Medicine

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要